AI in myeloproliferative neoplasms can grade marrow fibrosis and predict survival, but authors say prospective, outcome-focused trials are needed first.
|Articles|May 1, 1999
The American Journal of Managed Care
- May 1999
- Volume 5
- Issue 5
Quality of Care for Chronic Illness in Primary Care: Opportunities for Improvement in Process and Outcome Measures
Author(s)Steven M. Ornstein, MD, Ruth G. Jenkins, MS
Advertisement
Articles in this issue
Advertisement
Related to this article
Home-based oncology transforms practice transformation with clear bagging, protecting Medicare reimbursement, provider control, and lower costs for patients, health systems, and payers.
Costs of multimorbidity in older adults are climbing faster than its disability toll, and study authors say policy should look past single-disease programs.
October's FDA approvals included the introduction of 5 non-oncology treatment options across specialties.
PBM reform, Medicare Advantage exits, and the 340B rebate pilot are reshaping drug access. Here is what payers need to know heading into 2027.
Bispecific programs differ by practice size, but shared core components can guide adaptation, experts said at a webinar for the Bispecifics Network.
Bipolar disorder often goes undiagnosed for years, and clinicians need to separate mood episodes from normal emotions and keep patients on treatment.
A phase 4 study found 69% of patients with OAB were consistently satisfied with vibegron at 12 months, with exploratory persistence of 59.8%.
Advertisement
Advertisement
Trending on AJMC
1
Four Major Idiopathic Pulmonary Fibrosis Advances From 2026
2
Kidney Week 2026 Recap: IgAN Advances, Value-Based Care, CKD Care Gaps
3
Disability, Economic Toll of Multimorbidity Climb in Older Adults
4
FAQ: PBM Reform, 340B, and Medicare Shifts Payers Face in 2027
5